---
figid: PMC8261291__fimmu-12-687458-g001
figtitle: Targeting Bruton’s Tyrosine Kinase in CLL
organisms:
- Helicobacter pylori
- atypical mycobacterium
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
- unidentified
- Aklioshbomyces papillarum
- NA
pmcid: PMC8261291
filename: fimmu-12-687458-g001.jpg
figlink: /pmc/articles/PMC8261291/figure/f1/
number: F1
caption: B cell receptor signaling pathway. Activated B cell receptor (BCR) signaling
  is an antigen-dependent process utilizing the canonical nuclear factor-κB (NF-κB)
  pathway. Antigen binding by surface immunoglobulin initiates BCR signaling, resulting
  in coupling and autophosphorylation of the CD79A/CD79B heterodimer by Src family
  kinases. The phosphorylation of the immunoreceptor tyrosine-based activation motifs
  recruits a cascade of signaling molecules. These include LYN tyrosine kinase (LYN),
  spleen tyrosine kinase (SYK), Bruton’s tyrosine kinase (BTK), phospholipase Cγ2
  (PLCγ2), and protein kinase C (PKC), which lead to activation of NF-κB, phosphatidylinositol
  3-kinase (PI3K) and ERK. Tonic BCR is an antigen-independent process that maintains
  B cell survival through PI3K-AKT-mTOR signaling rather than NF-κB. BLNK, B-cell
  linker; ERK, extracellular signal-regulated kinase; IgH, immunoglobulin heavy chain;
  IgL, immunoglobulin light chain; mTOR, mammalian target of rapamycin; P, phosphorylation.
papertitle: Targeting Bruton’s Tyrosine Kinase in CLL.
reftext: Inhye E. Ahn, et al. Front Immunol. 2021;12:687458.
year: '2021'
doi: 10.3389/fimmu.2021.687458
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: Bruton’s tyrosine kinase | chronic lymphocytic leukemia | B-cell receptor
  signaling pathway | ibrutinib | acalabrutinib | zanubrutinib
automl_pathway: 0.9413612
figid_alias: PMC8261291__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Canis lupus familiaris
redirect_from: /figures/PMC8261291__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8261291__fimmu-12-687458-g001.html
  '@type': Dataset
  description: B cell receptor signaling pathway. Activated B cell receptor (BCR)
    signaling is an antigen-dependent process utilizing the canonical nuclear factor-κB
    (NF-κB) pathway. Antigen binding by surface immunoglobulin initiates BCR signaling,
    resulting in coupling and autophosphorylation of the CD79A/CD79B heterodimer by
    Src family kinases. The phosphorylation of the immunoreceptor tyrosine-based activation
    motifs recruits a cascade of signaling molecules. These include LYN tyrosine kinase
    (LYN), spleen tyrosine kinase (SYK), Bruton’s tyrosine kinase (BTK), phospholipase
    Cγ2 (PLCγ2), and protein kinase C (PKC), which lead to activation of NF-κB, phosphatidylinositol
    3-kinase (PI3K) and ERK. Tonic BCR is an antigen-independent process that maintains
    B cell survival through PI3K-AKT-mTOR signaling rather than NF-κB. BLNK, B-cell
    linker; ERK, extracellular signal-regulated kinase; IgH, immunoglobulin heavy
    chain; IgL, immunoglobulin light chain; mTOR, mammalian target of rapamycin; P,
    phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - RN7SL263P
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - NFKB1
  - CD79A
  - LYN
  - SYK
  - BLNK
  - BTK
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CD19
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - Bcr
  - Akt1
  - Pik3r1
  - Nfkb1
  - Cd79a
  - Lyn
  - Syk
  - Blnk
  - Btk
  - Plcg2
  - Cd19
  - Ephb2
  - Mapk1
  - Mtor
---
